Our faculty conduct research to provide evidence to help drug prescribers make informed decisions for their patients. This research examines the intersections of cost, value, quality, and health benefits.
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
PI: Katie Suda, PharmD, MS
Funding Source: NIH/NIDCR; August 2022 - April 2027
Machine-Learning Prediction and Reducing Overdoses with EHR Nudges (mPROVEN)
PI: Walid Gellad, MD, MPH
Funding Source: NIH/NIDA; July 2022 - April 2027
Developing a provider-facing intervention to address cost-related medication restrictions and improve medication use in patients with type 2 diabetes
PI: Jing Luo, MD, MPH
Funding Source: NIH/NIDDK; May 2021 - February 2025
Evidence-based Clinical Practice Guideline for the Management of Acute Dental Pain: Development, Implementation, and Evaluation Using Data Analytics to Target An Implementation Strategy
Co-I: Katie Suda, PharmD
Funding Source: FDA; September 2020 - August 2023
The Development, Validation, and Application of a Claims-Based Metric of Low-Value Prescribing in Older Adults
PI: Thomas Radomski, MD, MS
Funding Source: NIH/NIA; August 2019 - June 2024